Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Isosorbide dinitrate is a moderate to long-acting oral organic nitrate used for the relief and prophylactic management of angina pectoris and in the treatment of heart failure. It works by relaxing blood vessels (vasodilation), which decreases the workload on the heart and increases oxygen supply to cardiac tissue. The drug acts as a prodrug that is converted to nitric oxide (NO), which activates guanylate cyclase (specifically atrial natriuretic peptide receptor 1). This leads to increased cyclic guanosine monophosphate (cGMP) levels in smooth muscle cells and results in vasodilation. It is particularly useful for preventing angina attacks when taken regularly and has also been used with hydralazine for heart failure due to systolic dysfunction[1][2][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on isosorbide dinitrate.